Nitrofurantoin Dosing and Use for Uncomplicated Cystitis

Recommended Dosing Regimen (IDSA/ESMID)

For otherwise healthy adults with uncomplicated cystitis, prescribe nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5–7 days, provided the patient’s creatinine clearance is ≥30 mL/min. 1, 2, 3
The IDSA/ESMID guidelines designate nitrofurantoin as a first‑line agent for this indication. 1

Nitrofurantoin is safe and effective when the patient’s creatinine clearance is ≥30 mL/min; lower values risk sub‑therapeutic urinary concentrations and toxicity. 2, 3

A 5‑day course achieves clinical cure in ≈90 % of patients and microbiological cure in ≈92 %, which is equivalent to a 7‑day course. 4, 6
Overall clinical cure rates across studies range from 88 % to 93 %. 4, 6, 7
Microbiological cure rates range from 86 % to 92 %. 4, 6, 7
Late clinical cure (assessment after therapy) is observed in 84 % to 89 % of patients. 6, 8
Compared with fosfomycin, nitrofurantoin provides a higher microbiological cure rate (86 % vs 78 %, P = 0.02). 6, 7

Nitrofurantoin macrocrystals 50–100 mg four times daily for 5 days is an alternative schedule. 2
A prolonged‑release formulation of 100 mg twice daily for 5 days is also acceptable. 2
Twice‑daily dosing is strongly preferred because it improves adherence and yields efficacy comparable to more frequent dosing. 1, 2

Do not use nitrofurantoin for suspected pyelonephritis or other upper‑tract infections due to inadequate tissue penetration. 1, 3
Common, generally mild adverse effects include nausea (dose‑related, mitigated by taking with food) and headache. 6, 7

In men with uncomplicated cystitis, a 7‑day regimen is suggested to account for anatomical differences. 3

Nitrofurantoin causes minimal disruption of gut and vaginal microbiota, preserving normal flora. 1
It exhibits low resistance rates among common uropathogens. 8
Despite limited systemic absorption, it achieves high urinary concentrations, ensuring effective bacterial eradication. 3